The increasing incidence of osteoporosis indicates that the disease is a serious public health problem, with about 200 million people being affected worldwide. The aims of this research are to assess the awareness and knowledge about osteoporosis in relation to risk factors, health condition, supplementation used, socio-demographic factors and other variables among osteoporosis patients. The study was conducted in 2016–2018 in osteoporosis clinics in Poland. The study involved 312 patients with a diagnosis of osteoporosis. In the diagnostic survey method, the authors’ own questionnaire was used. The results indicate that the more frequent the symptoms associated with the disease, the lower the general self-assessment of the health condition of the respondents (rho = −0.682, p < 0.001). In addition, almost half of the respondents stated that their knowledge of osteoporosis is negligible. Moreover, the use of dietary supplements significantly differentiated respondents in terms of health self-assessed (p < 0.001), and it is noteworthy that users of dietary supplements assessed their health significantly better. We also saw a statistically significant relationship between the self-assessment of knowledge about osteoporosis and the use of dietary supplements (p < 0.001). Accordingly, significantly more respondents rating their knowledge as good or very good used dietary supplements. The conducted study demonstrates the need to educate patients and implement educational programs at central and provincial levels to improve patient knowledge concerning the disease. Supporting adaptation to chronic diseases and appropriate therapeutic management may contribute to improved osteoporosis treatment and enhanced patient quality of life.

Introduction: Prostate cancer is the second most commonly diagnosed malignant tumor worldwide and poses a significant challenge to public health. This systematic review and meta-analysis aims to investigate the association between diabetes mellitus and the risk of developing prostate cancer. Methods: We conducted a search of PubMed, Embase, and the Cochrane Library from 1998 to 2024. The risk of bias within the included studies was assessed using the Newcastle–Ottawa Scale. The DerSimonian–Laird random-effect model was employed for the meta-analysis. Heterogeneity was evaluated using a forest plot and statistically assessed via the Q test, I² index, and p-values. Results: Forty-three studies involving a total of 3,746,769 patients were included. Both case–control (pOR = 0.68, 95% CI: 0.61–0.97; I² = 92.24%) and cohort studies (pRR = 0.71, 95% CI: 0.59–0.99; I² = 85.41%) suggest that diabetes mellitus is associated with a reduced risk of prostate cancer, though with significant heterogeneity (p < 0.05). Subgroup analysis revealed that the risk of developing prostate cancer was significantly higher in patients with a family history of prostate cancer (pRR = 1.25, 95% CI: 1.16–1.35; I² = 69.51%). Conclusions: Our meta-analysis of recent observational studies indicates that diabetes mellitus is associated with a reduced risk of developing prostate cancer.

Background: Uveal melanoma (UM) is a relatively rare malignancy, yet it remains the most common primary intraocular cancer in adults. Several risk factors have been identified, including light iris color, fair skin tone, and cutaneous freckles. Methods: The aim of this article was an overview of the treatment methods for uveal melanoma, with a particular focus on emerging therapies such as tebentafusp and da-rovasertib. The research method was a review of the latest literature. Results: Genetic studies have uncovered key mutations in GNAQ and GNA11, which significantly contribute to UM pathogenesis. Treatment selection depends on tumor location and disease stage. In localized disease, radiotherapy—especially brachytherapy—is commonly used and generally effective. However, the prognosis worsens significantly once distant metastases, most often to the liver, develop, as no standard systemic therapy has demonstrated high efficacy in this setting. Recent years have seen the emergence of promising therapies, including tebentafusp, which stimulates immune responses against gp100-expressing melanoma cells, and darovasertib, a potent PKC inhibitor that targets MAPK pathway activation driven by GNAQ/GNA11 mutations. Both agents have shown encouraging tolerability; tebentafusp has demonstrated clinical benefit in Phase II and III trials, while darovasertib is still under investigation. Additionally, melphalan-based liver-directed therapy, particularly via hepatic arterial infusion (approved by the FDA), has shown potential in controlling liver-dominant disease in metastatic UM. This localized approach may provide significant benefit for patients with limited extrahepatic spread. Conclusions: Future research should focus on optimizing these novel strategies—tebentafusp, darovasertib, melphalan, and combination therapies—and on expanding our understanding of UM’s molecular drivers to enable the development of more effective, personalized treatments.

Couvade syndrome occurs when expectant fathers experience psychological and somatic symptoms typical of pregnancy. Common somatic symptoms include gastrointestinal problems, toothache, heartburn, fatigue and back pain, while anxiety is the most commonly reported psychological symptom. Symptoms typically manifest during the first trimester of the partner’s pregnancy, decrease or disappear during the second trimester, increase during the third trimester, and usually resolve after delivery. The aetiology of Couvade’s syndrome remains unclear, with psychoanalytic theories suggesting paternal anxiety and feelings of marginalisation. Hormonal changes, including increased cortisol, estradiol, prolactin and decreased testosterone levels during the third trimester, are also thought to be contributing factors. The prevalence varies widely, from 11% to 97%, depending on the population studied. Despite its reported prevalence, research into Couvade’s syndrome is limited, especially studies involving closely related women with similar symptoms. The findings highlight the need for further research to better understand this phenomenon and its impact on family dynamics during pregnancy.

Introduction and Objective: Voyeurism is characterized by recurrent and intense sexual arousal derived from observing unsuspecting individuals who are naked, disrobing, or engaging in sexual activity. Suggested risk factors for developing voyeurism include childhood sexual abuse, substance misuse, hypersexuality, emotional dysregulation, poor mental health, maladaptive coping strategies, and external pressures The aim of this publication is to discuss various aspects of voyeurism based on the latest literature.Review Methods: The PubMed database was searched to find scientific articles in which the terms “voyeurism” or “voyeuristic” appear in the title, abstract, or keywords.Brief Description of the State of Knowledge: Estimating the global prevalence of voyeurism is challenging due to inconsistent data, with reported rates ranging from over 10% to approximately 30–40%. Studies consistently indicate that voyeuristic behavior is more common among men. It often exhibits a compulsive and repetitive nature and can serve as a precursor to other sexual crimes, such as sexual sadism or pedophilia. Treatment primarily involves cognitive behavioral therapy (CBT), with pharmacological support using SSRIs like fluoxetine and paroxetine, showing effectiveness. Summary: The authors highlight the importance of further exploration into this topic and emphasize the need for a more accurate understanding of voyeurism's prevalence in the general population, as current data may be inconclusive.